ProKidney Corp. (PROK)
NASDAQ: PROK · IEX Real-Time Price · USD
3.880
-0.175 (-4.32%)
At close: May 20, 2024, 4:00 PM
4.070
+0.190 (4.90%)
After-hours: May 20, 2024, 4:52 PM EDT
ProKidney Employees
ProKidney had 163 employees on December 31, 2023. The number of employees increased by 76 or 87.36% compared to the previous year.
Employees
163
Change (1Y)
76
Growth (1Y)
87.36%
Revenue / Employee
n/a
Profits / Employee
-$216,534
Market Cap
898.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 163 | 76 | 87.36% |
Dec 31, 2022 | 87 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
PROK News
- 10 days ago - ProKidney Reports Business Updates and First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations - GlobeNewsWire
- 2 months ago - ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - ProKidney to Participate in Jefferies Biotech on the Bay Summit - GlobeNewsWire
- 6 months ago - ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer - GlobeNewsWire
- 6 months ago - ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference - GlobeNewsWire
- 6 months ago - ProKidney Reports Third Quarter Financial Results - GlobeNewsWire
- 6 months ago - ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates - GlobeNewsWire